Pilot Study of Cabazitaxel and Paclitaxel in HER2 Negative Breast Cancer

NCT03048942 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

160

Enrollment

OTHER

Sponsor class

Conditions

HER2 Negative Metastatic Breast Cancer

Interventions

DRUG: Cabazitaxel
DRUG: Paclitaxel

Sponsor

University Hospitals Bristol and Weston NHS Foundation Trust